| Oral melphalan and prednisone chemotherapy plus thalidomide compared with melphalan and prednisone alone in elderly patients with multiple myeloma: randomised controlled trial A Palumbo, S Bringhen, T Caravita, E Merla, V Capparella, V Callea, ... The Lancet 367 (9513), 825-831, 2006 | 984 | 2006 |
| Inherited thrombophilia: pathogenesis, clinical syndromes, and management [see comments] V De Stefano, G Finazzi, PM Mannucci | 684 | 1996 |
| Cardiovascular events and intensity of treatment in polycythemia vera R Marchioli, G Finazzi, G Specchia, R Cacciola, R Cavazzina, D Cilloni, ... N Engl J Med 368, 22-33, 2013 | 654 | 2013 |
| The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutation V De Stefano, I Martinelli, PM Mannucci, K Paciaroni, P Chiusolo, ... New England Journal of Medicine 341 (11), 801-806, 1999 | 631 | 1999 |
| Prevention of venous thromboembolism: International Consensus Statement Guidelines compiled in accordance with the scientific evidence AN Nicolaides International Angiology 20 (1), 1, 2001 | 561* | 2001 |
| Clinical profile of homozygous JAK2 617V> F mutation in patients with polycythemia vera or essential thrombocythemia AM Vannucchi, E Antonioli, P Guglielmelli, A Rambaldi, G Barosi, ... Blood 110 (3), 840-846, 2007 | 528 | 2007 |
| Different risks of thrombosis in four coagulation defects associated with inherited thrombophilia: a study of 150 families I Martinelli, PM Mannucci, V De Stefano, E Taioli, V Rossi, F Crosti, ... Blood, The Journal of the American Society of Hematology 92 (7), 2353-2358, 1998 | 508 | 1998 |
| Natural history and risk factors for thrombosis in 360 patients with antiphospholipid antibodies: a four-year prospective study from the Italian Registry G Finazzi, V Brancaccio, M Moia, N Ciavarella, MG Mazzucconi, ... The American journal of medicine 100 (5), 530-536, 1996 | 499 | 1996 |
| Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism J Emmerich, FR Rosendaal, M Cattaneo, M Margaglione, V De Stefano, ... Thromb Haemost 86 (3), 809-816, 2001 | 469 | 2001 |
| Leukocytosis as a major thrombotic risk factor in patients with polycythemia vera R Landolfi, L Di Gennaro, T Barbui, V De Stefano, G Finazzi, RM Marfisi, ... Blood 109 (6), 2446-2452, 2007 | 425 | 2007 |
| Development and validation of an International Prognostic Score of thrombosis in World Health Organization–essential thrombocythemia (IPSET-thrombosis) T Barbui, G Finazzi, A Carobbio, J Thiele, F Passamonti, E Rumi, ... Blood 120 (26), 5128-5133, 2012 | 419 | 2012 |
| Prothrombin G20210A mutant genotype is a risk factor for cerebrovascular ischemic disease in young patients V De Stefano, P Chiusolo, K Paciaroni, I Casorelli, E Rossi, M Molinari, ... Blood, The Journal of the American Society of Hematology 91 (10), 3562-3565, 1998 | 320 | 1998 |
| Bortezomib-thalidomide-dexamethasone is superior to thalidomide-dexamethasone as consolidation therapy after autologous hematopoietic stem cell transplantation in patients with … M Cavo, L Pantani, MT Petrucci, F Patriarca, E Zamagni, D Donnarumma, ... Blood 120 (1), 9-19, 2012 | 316* | 2012 |
| Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatments V De Stefano, T Za, E Rossi, AM Vannucchi, M Ruggeri, E Elli, C Micò, ... haematologica 93 (3), 372-380, 2008 | 293 | 2008 |
| Dexamethasone plus rituximab yields higher sustained response rates than dexamethasone monotherapy in adults with primary immune thrombocytopenia F Zaja, M Baccarani, P Mazza, M Bocchia, L Gugliotta, A Zaccaria, ... Blood 115 (14), 2755-2762, 2010 | 280 | 2010 |
| Screening for inherited thrombophilia: indications and therapeutic implications V De Stefano, E Rossi, K Paciaroni, G Leone haematologica 87 (10), 1095-1108, 2002 | 247 | 2002 |
| Epidemiology of factor V Leiden: clinical implications V de Stefano, P Chiusolo, K Paciaroni, G Leone Seminars in thrombosis and hemostasis 24 (04), 367-379, 1998 | 244 | 1998 |
| Inherited thrombophilia and first venous thromboembolism during pregnancy and puerperium I Martinelli, V De Stefano, E Taioli, K Paciaroni, E Rossi, MM Pier Thrombosis and haemostasis 87 (05), 791-795, 2002 | 240 | 2002 |
| Incidence of the JAK2 V617F mutation among patients with splanchnic or cerebral venous thrombosis and without overt chronic myeloproliferative disorders V De Stefano, A Fiorini, E Rossi, T Za, G Farina, P Chiusolo, S Sica, ... Journal of Thrombosis and Haemostasis 5 (4), 708-714, 2007 | 229 | 2007 |
| Clinical manifestations and management of inherited thrombophilia: retrospective analysis and follow-up after diagnosis of 238 patients with congenital deficiency of … V De Stefano, G Leone, S Mastrangelo, A Tripodi, F Rodeghiero, ... Thrombosis and haemostasis 72 (09), 352-358, 1994 | 212 | 1994 |
